PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.\', \'Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.\', \'Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada.\', \'Thomas Jefferson Medical College and the Heart Center, Wynnewood, PA, USA.\', \'Duke Clinical Research Institute, Duke University Medical Center, Duke Health, Durham, NC, USA.\', \'Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/eurheartj/ehaa697
?:hasPublicationType
?:journal
  • European heart journal
is ?:pmid of
?:pmid
?:pmid
  • 32984892
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.315
?:rankingScore_hIndex
  • 254
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32984892>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32984892>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all